Limfotoksin beta receptor

edit
Limfotoksin beta receptor (TNFR superfamilija, član 3)

Kristalografska struktura peptida sa 24 ostatka iz limfotoksin-B receptora vezanog za TRAF3.[1]
Dostupne strukture
1RF3
Identifikatori
SimboliLTBR; CD18; D12S370; LT-BETA-R; TNF-R-III; TNFCR; TNFR-RP; TNFR2-RP; TNFRSF3
Vanjski IDOMIM: 600979 MGI: 104875 HomoloGene: 1753 GeneCards: LTBR Gene
Ontologija gena
Molekularna funkcija aktivnost transmembranskog receptora
proteinsko vezivanje
Celularna komponenta membrana
integralno sa membranom
Biološki proces apoptoza
imunski respons
prenos signala
positivna regulacija I-kapaB kinaza/NF-kapaB kaskade
Pregled RNK izražavanja
podaci
Ortolozi
VrstaČovekMiš
Entrez405517000
EnsemblENSG00000111321n/a
UniProtP36941n/a
RefSeq (mRNA)NM_002342XM_982227
RefSeq (protein)NP_002333XP_987321
Lokacija (UCSC)Chr 12:
6.36 - 6.37 Mb
n/a
PubMed pretraga[1][2]

Limfotoksin beta receptor je receptor za limfotoksin koji je kod ljudi kodiran LTBR genom.[2][3][4]

Funkcija

Protein kodiran ovim genom je član TNF familije receptora. On je izražen na površini većine ćelijskih tipova, uključujući ćelije epitelnog i mijeloidnog porekla, ali ne na T i B limfocitima. Ovaj protein specifično vezuje limfotoksin membransku formu (kompleks limfotoksina-alfa i limftoksina-beta se formira). Limftoksin-beta i njegov ligand učestvuju u razvoju i organizaciji limfoidnog tkiva. Aktivacija ovog proteina može da podstakne apoptozu.[2]

Ne samp da LTBR pomaže u podsticanju apoptoze, on može da dovede do oslobađanja citokina interleukin 8. Prekomerno LTBR izražavanje u HEK293 ćelima povećava IL-8 promotorsku aktivnost, i dovodi do IL-8 oslobađanja. LTBR je takođe esencijalan za razvoj i organizaciju sekundarnih limfoidnih organa i oslobađanje drugih hemokina.[5]

Struktura

Ramačandranov dijagram pokazuje da je 64.6% ostataka u poželjnom regionu.[6] Ova structura je ustanovljena putem difrakcije X-zraka. Njena rezolucija je 3.50 Å. Alfa i beta uglovi su 90 stepeni, dok je gama ugao 120 stepeni.

Interakcije

Za limfotoksin beta receptor je bilo pokazano da interaguje sa Dijablo homologom[7] i TRAF3.[8][9][10]

Reference

  1. PDB 1RF3; Li C, Norris PS, Ni CZ, Havert ML, Chiong EM, Tran BR, Cabezas E, Reed JC, Satterthwait AC, Ware CF, Ely KR (December 2003). „Structurally distinct recognition motifs in lymphotoxin-beta receptor and CD40 for tumor necrosis factor receptor-associated factor (TRAF)-mediated signaling”. J. Biol. Chem. 278 (50): 50523–9. DOI:10.1074/jbc.M309381200. PMID 14517219. 
  2. 2,0 2,1 „Entrez Gene: LTBR lymphotoxin beta receptor (TNFR superfamily, member 3)”. 
  3. Baens M, Chaffanet M, Cassiman JJ, van den Berghe H, Marynen P (April 1993). „Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid”. Genomics 16 (1): 214–8. DOI:10.1006/geno.1993.1161. PMID 8486360. 
  4. Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA (April 1994). „A lymphotoxin-beta-specific receptor”. Science (journal) 264 (5159): 707–10. DOI:10.1126/science.8171323. PMID 8171323. 
  5. Chang YH, Hsieh SL, Chen MC, Lin WW (August 2002). „Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation”. Exp. Cell Res. 278 (2): 166–74. DOI:10.1006/excr.2002.5573. PMID 12169272. 
  6. „MolProbity Ramachandran analysis”. Arhivirano iz originala na datum 2012-10-12. 
  7. Kuai, Jun; Nickbarg Elliott, Wooters Joe, Qiu Yongchang, Wang Jack, Lin Lih-Ling (April 2003). „Endogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosis”. J. Biol. Chem. (United States) 278 (16): 14363–9. DOI:10.1074/jbc.M208672200. ISSN 0021-9258. PMID 12571250. 
  8. VanArsdale, T L; VanArsdale S L, Force W R, Walter B N, Mosialos G, Kieff E, Reed J C, Ware C F (March 1997). „Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB”. Proc. Natl. Acad. Sci. U.S.A. (UNITED STATES) 94 (6): 2460–5. DOI:10.1073/pnas.94.6.2460. ISSN 0027-8424. PMC 20110. PMID 9122217. 
  9. Wu, M Y; Wang P Y, Han S H, Hsieh S L (April 1999). „The cytoplasmic domain of the lymphotoxin-beta receptor mediates cell death in HeLa cells”. J. Biol. Chem. (UNITED STATES) 274 (17): 11868–73. DOI:10.1074/jbc.274.17.11868. ISSN 0021-9258. PMID 10207006. 
  10. Marsters, S A; Ayres T M, Skubatch M, Gray C L, Rothe M, Ashkenazi A (May 1997). „Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1”. J. Biol. Chem. (UNITED STATES) 272 (22): 14029–32. DOI:10.1074/jbc.272.22.14029. ISSN 0021-9258. PMID 9162022. 

Literatura

  • Elewaut D, Ware CF (2007). „The unconventional role of LT alpha beta in T cell differentiation.”. Trends Immunol. 28 (4): 169–75. DOI:10.1016/j.it.2007.02.005. PMID 17336158. 
  • Browning JL, Ngam-ek A, Lawton P, et al. (1993). „Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface.”. Cell 72 (6): 847–56. DOI:10.1016/0092-8674(93)90574-A. PMID 7916655. 
  • Crowe PD, VanArsdale TL, Walter BN, et al. (1994). „A lymphotoxin-beta-specific receptor.”. Science 264 (5159): 707–10. DOI:10.1126/science.8171323. PMID 8171323. 
  • Baens M, Chaffanet M, Cassiman JJ, et al. (1993). „Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid.”. Genomics 16 (1): 214–8. DOI:10.1006/geno.1993.1161. PMID 8486360. 
  • Baens M, Aerssens J, van Zand K, et al. (1996). „Isolation and regional assignment of human chromosome 12p cDNAs.”. Genomics 29 (1): 44–52. DOI:10.1006/geno.1995.1213. PMID 8530100. 
  • Wang X, Bornslaeger EA, Haub O, et al. (1996). „A candidate gene for the amnionless gastrulation stage mouse mutation encodes a TRAF-related protein.”. Dev. Biol. 177 (1): 274–90. DOI:10.1006/dbio.1996.0162. PMID 8660894. 
  • Nakano H, Oshima H, Chung W, et al. (1996). „TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor.”. J. Biol. Chem. 271 (25): 14661–4. DOI:10.1074/jbc.271.25.14661. PMID 8663299. 
  • Matsumoto M, Hsieh TY, Zhu N, et al. (1997). „Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor.”. J. Virol. 71 (2): 1301–9. PMC 191185. PMID 8995654. 
  • VanArsdale TL, VanArsdale SL, Force WR, et al. (1997). „Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB.”. Proc. Natl. Acad. Sci. U.S.A. 94 (6): 2460–5. DOI:10.1073/pnas.94.6.2460. PMC 20110. PMID 9122217. 
  • Wu MY, Hsu TL, Lin WW, et al. (1997). „Serine/threonine kinase activity associated with the cytoplasmic domain of the lymphotoxin-beta receptor in HepG2 cells.”. J. Biol. Chem. 272 (27): 17154–9. DOI:10.1074/jbc.272.27.17154. PMID 9202035. 
  • Chen CM, You LR, Hwang LH, Lee YH (1997). „Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor.”. J. Virol. 71 (12): 9417–26. PMC 230246. PMID 9371602. 
  • Mizushima S, Fujita M, Ishida T, et al. (1998). „Cloning and characterization of a cDNA encoding the human homolog of tumor necrosis factor receptor-associated factor 5 (TRAF5).”. Gene 207 (2): 135–40. DOI:10.1016/S0378-1119(97)00616-1. PMID 9511754. 
  • Krajewska M, Krajewski S, Zapata JM, et al. (1998). „TRAF-4 expression in epithelial progenitor cells. Analysis in normal adult, fetal, and tumor tissues.”. Am. J. Pathol. 152 (6): 1549–61. PMC 1858434. PMID 9626059. 
  • Boussaud V, Soler P, Moreau J, et al. (1999). „Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in human lung.”. Eur. Respir. J. 12 (4): 926–31. DOI:10.1183/09031936.98.12040926. PMID 9817170. 
  • Murphy M, Walter BN, Pike-Nobile L, et al. (1999). „Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues.”. Cell Death Differ. 5 (6): 497–505. DOI:10.1038/sj.cdd.4400374. PMID 10200501. 
  • Wu MY, Wang PY, Han SH, Hsieh SL (1999). „The cytoplasmic domain of the lymphotoxin-beta receptor mediates cell death in HeLa cells.”. J. Biol. Chem. 274 (17): 11868–73. DOI:10.1074/jbc.274.17.11868. PMID 10207006. 
  • Yu KY, Kwon B, Ni J, et al. (1999). „A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.”. J. Biol. Chem. 274 (20): 13733–6. DOI:10.1074/jbc.274.20.13733. PMID 10318773. 
  • Rooney IA, Butrovich KD, Glass AA, et al. (2000). „The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells.”. J. Biol. Chem. 275 (19): 14307–15. DOI:10.1074/jbc.275.19.14307. PMID 10799510. 
  • Langeggen H, Berge KE, Johnson E, Hetland G (2003). „Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro.”. Inflammation 26 (3): 103–10. DOI:10.1023/A:1015585530204. PMID 12083416. 
  • Chang YH, Hsieh SL, Chen MC, Lin WW (2002). „Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation.”. Exp. Cell Res. 278 (2): 166–74. DOI:10.1006/excr.2002.5573. PMID 12169272. 

Spoljašnje veze

  • MeSH Lymphotoxin+beta+Receptor
  • p
  • r
  • u
Hemokinski receptor
(GPCR)
CC hemokinski receptori
CCR1  CCRL1  CCR2  CCRL2  CCR3  CCR4  CCR5  CCR6  CCR7  CCR8  CCR9  CCR10
CXC hemokinski receptori
IL-8 (CXCR1, CXCR2)  CXCR3  CXCR4  CXCR5  CXCR6  CXCR7
Drugi
CCBP2  CMKLR1  CX3CR1  XCR1
TNF receptor
1-10
TNFRSF1 (CD120)  TNFRSF1A (CD120a)  TNFRSF1B (CD120b)  TNFRSF3 (Limfotoksin beta receptor)  TNFRSF4 (CD134)  TNFRSF5 (CD40)  TNFRSF6 (FAS)  TNFRSF6B  TNFRSF7 (CD27)  TNFRSF8 (CD30)  TNFRSF9 (CD137)
11-20
TNFRSF10A (CD261)  TNFRSF10B (CD262)  TNFRSF10C (CD263)  TNFRSF10D (CD264)  TNFRSF11A (CD265/RANK)  TNFRSF11B (Osteoprotegerin)  TNFRSF12A (CD266)  TNFRSF13B (CD267)  TNFRSF13C  TNFRSF14 (CD268)  TNFRSF16 (Receptor nervnog faktora rasta)  TNFRSF17 (CD269)  TNFRSF18  TNFRSF19
21-25
TNFRSF21  TNFRSF25  TNFRSF27
JAK-STAT
zajednički beta lanac: Interleukinski receptori (3, 5)  GM-CSF

zajednički gama lanac: Interleukinski receptori (2, 4, 7, 9, 13/A1/A2, 15, 21)

gp130 koristeći: Interleukinski receptori (6, 27)  Onkostatin M  Leukemija inhibitorni faktor

drugi Interleukinski receptori (11/A, 12/B1/B2, 23)

drugi CSF receptori (EPO, G-CSF, Trombopoietin)

Hormonski receptor: GH  prolaktin
Tip II
Interleukini (10, 20, 22, 28)  interferon (-α/β, -γ)
Ig superfamilija
CSF1  C-kit  IL-1 (IL1R1, IL1R2)  IL-18
S/T
TGF-beta (1, 2)
Drugi
IL-17 (IL17RA, IL17RB, IL17RC, IL17RD, IL17RE)
B trdu: peptidi (nrpl/grfl/cytl/horl), receptori (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd, signalni putevi (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)
  • p
  • r
  • u
Receptori za antitela:
Fc receptor
Epsilon (ε)
FcεRI  (FcεRII je C-tip lektin)
Gama (γ)
FcγRI • FcγRII • FcγRIII • Neonatalni
Alfa (α)/mu (μ)
FcαRI  Fcα/μR
Sekretorni
Polimerni imunoglobulinski receptor
Receptori za antigene
B ćelije
Antigenski receptor
BCR
Koreceptori
stimuliše: CD21/CD19/CD81
inhibira: CD22
Pomoćni molekuli
Ig-α/Ig-β (CD79)
T ćelije
Ligandi
MHC (MHC klasa I i MHC klasa II)
Antigenski receptor
TCR: TRA@  TRB@  TRD@  TRG@
Koreceptori
CD8 (sa dva glikoproteinska lanca CD8α i CD8β)  CD4
Pomoćni molekuli
CD3  CD3γ  CD3δ  CD3ε  ζ-lanac (CD3ζ i TCRζ)
Citokinski receptor
Pogledajte citokinski receptori
Receptori ćelija ubica slični IG
KIR2DL1, KIR2DL2, KIR2DL3, KIR2DL4, KIR2DL5A, KIR2DL5B, KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5, KIR3DL1, KIR3DL2, KIR3DL3, KIR3DS1
Leukocitni receptori slični IG
LILRA1  LILRA2  LILRA3  LILRA4  LILRA5  LILRA6  LILRB1  LILRB2  LILRB3  LILRB4  LILRB5  LILRA6  LILRA5
B trdu: peptidi (nrpl/grfl/cytl/horl), receptori (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd, signalni putevi (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)

M: LMC

ćelije/fis/auag/auab

imdf/ipig/hyps/tumr

proc, lek (L3/4)

  • p
  • r
  • u
Po familiji
IL-1 superfamilija
1 (1Ra) • 18 • 33
poput IL-6/gp130 koristeći
IL-10 familija
10 • 19 • 20 • 22 • 24 • 26
28 • 29
2/15 • 3 • 4 • 7 • 9 • 13 • 21
IL-12 familija
12 (B) • 23 • 27 • 35
Drugi
5 • 8 • 14 • 16 • 17/25 (A) • 32  • 34
CCL
1 • 2 • 3 • 4 • 5 • 6 • 7 • 8 • 9 • 10 • 11 • 12 • 13 • 14 • 15 • 16 • 17 • 18 • 19 • 20 • 21 • 22 • 23 • 24 • 25 • 26 • 27 • 28
CXCL
1 • 2 • 3 • 4 • 5 • 6 • 7 • 8 • 9 • 10 • 11 • 12 • 13 • 14 • 15 • 16 • 17
CX3CL
XCL
1 • 2
Glavni
TNF (ligand) superfamilija
CD70 • CD153 • CD154
alfa ( Pegilirani 2a, Pegilirani 2b), beta (1a, 1b)
Drugi
Po funkciji
B trdu: peptidi (nrpl/grfl/cytl/horl), receptori (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd, signalni putevi (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)
  • p
  • r
  • u
1-50
CD1 (a-c, 1A, 1D, 1E) • CD2 • CD3 (γ, δ, ε) • CD4 • CD5 • CD6 • CD7 • CD8 (a) • CD9 • CD10 • CD11 (a, b, c) • CD13 • CD14 • CD15 • CD16 (A, B) • CD18 • CD19 • CD20 • CD21 • CD22 • CD23 • CD24 • CD25 • CD26 • CD27 • CD28 • CD29 • CD30 • CD31 • CD32 (A, B) • CD33 • CD34 • CD35 • CD36 • CD37 • CD38 • CD39 • CD40 • CD41 • CD42 (a, b, c, d) • CD43 • CD44 • CD45 • CD46 • CD47 • CD48 • CD49 (a, b, c, d, e, f) • CD50
51-100
CD51 • CD52 • CD53 • CD54 • CD55 • CD56 • CD57 • CD58 • CD59 • CD61 • CD62 (E, L, P) • CD63 • CD64 (A, B, C) • CD66 (a, b, c, d, e, f) • CD68 • CD69 • CD70 • CD71 • CD72 • CD73 • CD74 • CD78 • CD79 (a, b) • CD80 • CD81 • CD82 • CD83 • CD84 • CD85 (a, d, e, h, j, k) • CD86 • CD87 • CD88 • CD89 • CD90 • CD91- CD92 • CD93 • CD94 • CD95 • CD96 • CD97 • CD98 • CD99 • CD100
101-150
CD101 • CD102 • CD103 • CD104 • CD105 • CD106 • CD107 (a, b) • CD108 • CD109 • CD110 • CD111 • CD112 • CD113 • CD114 • CD115 • CD116 • CD117 • CD118 • CD119 • CD120 (a, b) • CD121 (a, b) • CD122 • CD123 • CD124 • CD125 • CD126 • CD127 • CD129 • CD130 • CD131 • CD132 • CD133 • CD134 • CD135 • CD136 • CD137 • CD138 • CD140b • CD141 • CD142 • CD143 • CD144 • CD146 • CD147 • CD148 • CD150
151-200
CD151 • CD152 • CD153 • CD154 • CD155 • CD156 (a, b, c) • CD157 • CD158 (a, d, e, i, k) • CD159 (a, c) • CD160 • CD161 • CD162 • CD163 • CD164 • CD166 • CD167 (a, b) • CD168 • CD169 • CD170 • CD171 • CD172 (a, b, g) • CD174 • CD177 • CD178 • CD179 (a, b) • CD181 • CD182 • CD183 • CD184 • CD185 • CD186 • CD191 • CD192 • CD193 • CD194 • CD195 • CD196 • CD197 • CDw198 • CDw199 • CD200
201-250
CD201 • CD202b • CD204 • CD205 • CD206 • CD207 • CD208 • CD209 • CDw210 (a, b) • CD212 • CD213a (1, 2) • CD217 • CD218 (a, b) • CD220 • CD221 • CD222 • CD223 • CD224 • CD225 • CD226 • CD227 • CD228 • CD229 • CD230 • CD233 • CD234 • CD235 (a, b) • CD236 • CD238 • CD239 • CD240CE • CD241 • CD243 • CD244 • CD246 • CD247- CD248 • CD249
251-300
CD252 • CD253 • CD254 • CD256 • CD257 • CD258 • CD261 • CD262 • CD264 • CD265 • CD266 • CD267 • CD268 • CD269 • CD271 • CD272 • CD273 • CD274 • CD275 • CD276 • CD278 • CD279 • CD280 • CD281 • CD282 • CD283 • CD284 • CD286 • CD288 • CD289 • CD290 • CD292 • CDw293 • CD294 • CD295 • CD297 • CD298 • CD299
301-350
CD300A • CD301 • CD302 • CD303 • CD304 • CD305 • CD306 • CD307 • CD309 • CD312 • CD314 • CD315 • CD316 • CD317 • CD318 • CD320 • CD321 • CD322 • CD324 • CD325 • CD326 • CD328 • CD329 • CD331 • CD332 • CD333 • CD334 • CD335 • CD336 • CD337 • CD338 • CD339 • CD340 • CD344 • CD349 • CD350
  • p
  • r
  • u
Aktivatori/enzimi
Rano
C: C1Q/C1R/C1S - C4 (C4a) - C2

L: MASP1/MASP2 - MBL

A: Faktor B - Faktor D - Faktor P/Properdin
Srednje
C3 (C3a, C3b/iC3b) - C5 (C5a)
C3-konvertaza - C5-konvertaza
Kasno
MAC (C6, C7, C8, C9)
Inhibitori
CLA: C1-inhibitor - Faktor ubrzanja raspada/CD59 - Faktor I

CL: C4BP

A: Faktor H
Receptori komplementa
CR1 - CR2 - CR3 - CR4 - CD11b/CD11c/CD18 - Anafilatoksin (C3a, C5a)

M: LMC

ćelije/fis/auag/auab

imdf/ipig/hyps/tumr

proc, lek (L3/4)